Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Disulfide exchange in multimerization of von Willebrand factor and gel-forming mucins

Xianchi Dong, Timothy A. Springer

Blood (2021) 137 (9): 1263–1267.

https://doi.org/10.1182/blood.2020005989

Published: 2021

Includes: Supplemental data

Journal Articles

Lymphocyte Subpopulations and Expression of Immune Checkpoint Receptors PD-1 and Tim-3 in Patients with Chronic Myeloid Leukemia in a Discontinuation Trial

Fernanda S Seguro, MD, Felipe VR Maciel, MD, Guilherme O Lopes, Luciana Nardinelli, M.Sc, Vanderson Rocha, MD PhD, Israel Bendit, MD PhD

Blood (2019) 134 (Supplement_1): 1651.

https://doi.org/10.1182/blood-2019-125989

Published: 2019

Journal Articles

A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)

James R. Berenson, MD, Jennifer To, BS, Tanya M. Spektor, PhD, Daisy Martinez, Armando J. Sanchez, MBA, Carley Turner, CCRP, Regina Swift, Benjamin Eades, PharmD, Gary Schwartz, MD, Shahrooz Eshaghian, MD, Laura V. Stampleman, Robert A. Moss, MD, Youram Nassir, MD, Ravindranath Patel, MD, Alberto Bessudo, MD, Daniel Greenwald, MD, Ralph V. Boccia, MD, Stephen Lim, MD, Robert Vescio, MD

Blood (2019) 134 (Supplement_1): 1903.

https://doi.org/10.1182/blood-2019-131370

Published: 2019

Journal Articles

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Shernan Holtan, MD, Todd E. DeFor, MS, Armin Rashidi, MD PhD, Alexander Khoruts, MD, Christopher Staley, PhD, Lucie M Turcotte, MD, Pamala A. Jacobson, PharmD, Daniel J. Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2019) 134 (Supplement_1): 39.

https://doi.org/10.1182/blood-2019-129236

Published: 2019

Journal Articles

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Blood (2019) 134 (Supplement_1): 570.

https://doi.org/10.1182/blood-2019-128178

Published: 2019

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of MBG453 Added to Hypomethylating Agents (HMAs) in Patients (pts) with Intermediate, High, or Very High Risk Myelodysplastic Syndrome (MDS): Stimulus-MDS1

Amer M Zeidan, MD, Yasushi Miyazaki, MD PhD, Uwe Platzbecker, Kamel Malek, Julie Niolat, Flavia Kiertsman, Pierre Fenaux, MD PhD

Blood (2019) 134 (Supplement_1): 4259.

https://doi.org/10.1182/blood-2019-127041

Published: 2019

Journal Articles

The von Willebrand factor D′D3 assembly and structural principles for factor VIII binding and concatemer biogenesis

Xianchi Dong, Nina C. Leksa, Ekta Seth Chhabra, Joseph W. Arndt, Qi Lu, Kevin E. Knockenhauer, Robert T. Peters, Timothy A. Springer

Blood (2019) 133 (14): 1523–1533.

https://doi.org/10.1182/blood-2018-10-876300

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Platelet Protein Glycosylation in Immune Thrombocytopenia

Elena Monzón Manzano, Raul Justo Sanz, Stuart M Haslam, BSc PhD, Leow Ke Xuan, Anne Dell, PhD, Teresa Álvarez-Roman, Mónica Martín, María Isabel Rivas Pollmar, Ihosvany Fernandez-Bello, Miguel A. Canales, Victor Jimenez-Yuste, Nora Butta, PhD

Blood (2018) 132 (Supplement 1): 2437.

https://doi.org/10.1182/blood-2018-99-114568

Published: 2018

Journal Articles

Monitoring ESAM Expression Levels Reveals Autonomous Fluctuation of Leukemia Stem Cells By Autocrine/Paracrine Cytokine Signaling

Yasuhiro Shingai, MD, Takafumi Yokota, MD PhD, Takayuki Ozawa, MD, Tomoaki Ueda, Yukiko Doi, Tomohiko Ishibashi, Akira Tanimura, Michiko Ichii, MD PhD, Hirohiko Shibayama, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2018) 132 (Supplement 1): 3950.

https://doi.org/10.1182/blood-2018-99-111085

Published: 2018

Journal Articles

Identification of Molecular Markers of Tumor Cell Sensitivity and Resistance to Natural Killer Cells through Genome-Wide CRISPR Activation and CRISPR Editing Screens in Multiple Myeloma Cell Lines: Implications for Anti-Myeloma Immunotherapy

Sara Gandolfi, MD, Michal Sheffer, PhD, Emily Lowry, Olga Dashevsky, PhD, Ryosuke Shirasaki, MD PhD, Ricardo De Matos Simoes, PhD, Constantine S. Mitsiades, MD PhD

Blood (2018) 132 (Supplement 1): 1115.

https://doi.org/10.1182/blood-2018-99-118736

Published: 2018

Journal Articles

Nivolumab for Relapsed or Residual Haematological Malignancies after Allogeneic Haematopoietic Stem Cell Transplantation (NIVALLO)

Eric Wong, MBBS, Emily Dawson, Joanne Davis, PhD, Rachel Koldej, PhD, Mandy Ludford-Menting, Matthew Lansdown, Heather Lambie, Jeffrey Szer, MBBS, Andrew P. Grigg, MBBS, FRACP, FRCPA, MD, David Ritchie, MBChB, PhD FRACP, FRCPA

Blood (2018) 132 (Supplement 1): 4633.

https://doi.org/10.1182/blood-2018-99-112310

Published: 2018

Journal Articles

Molecular Resistance Mechanisms in Multiple Myeloma

Santiago Barrio Garcia, PhD, Umair Munawar, MS, BS, Thorsten Stuehmer, Hermann Einsele, MD, K. Martin Kortüm, MD

Blood (2018) 132 (Supplement 1): 471.

https://doi.org/10.1182/blood-2018-99-118700

Published: 2018

Journal Articles

Endothelial O-Glycoproteins Cooperate with Platelet CLEC-2 Signaling to Maintain Cerebrovascular Integrity during Mouse Development

Jianxin Fu, MD PhD, Jianhua Song, PhD, Lijun Xia, MD PhD

Blood (2018) 132 (Supplement 1): 76.

https://doi.org/10.1182/blood-2018-99-118929

Published: 2018

Journal Articles

Oral Nutrition Modulates the Intestinal Barrier Following Cytotoxic Therapy Via the Microbiome

Zaker I. Schwabkey, MD, Diana H. Wiesnoski, Dung Pham, Christopher A. Sanchez, Chia-Chi Chang, PhD, Mohamed A. Jamal, PhD, Robert R. Jenq, MD

Blood (2018) 132 (Supplement 1): 63.

https://doi.org/10.1182/blood-2018-99-110037

Published: 2018

Journal Articles

Identification and Molecular Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Niche Factor

Keane Jared Guillaume Kenswil, BSc, MSc, Christopher Adrian Jaramillo, MD, Zhen Ping, MSc, Si Chen, MSc, Remco Michiel Hoogenboezem, MSc, Maria Athina Mylona, PhD, Maria Niken Adisty, BSc, Eric Moniqué Johannes Bindels, PhD, Hans Stoop, PhD, King Hong Lam, MD PhD, Pieter Koen Bos, MD, Bram van Eerden, PhD, Tom Cupedo, PhD, Marc Hermanus Gerardus Petrus Raaijmakers, MD PhD

Blood (2017) 130 (Supplement 1): 2437.

https://doi.org/10.1182/blood.V130.Suppl_1.2437.2437

Published: 2017

Journal Articles

Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis

Rikhia Chakraborty, PhD BSc, MSc, Carl E. Allen, MD PhD, Amel Sengal, BS, Amos S. Gaikwad, PhD, Harshal Abhyankar, MS, Brooks Scull, Olive S. Eckstein, MD, Miriam Merad, MD, Kenneth L. McClain, MD PhD

Blood (2017) 130 (Supplement 1): 2280.

https://doi.org/10.1182/blood.V130.Suppl_1.2280.2280

Published: 2017

Journal Articles

Characteristics of CD4 + and CD8 + Memory T Cell Subsets from Peripheral and Bone Marrow in Patients with Acute Myeloid Leukemia

Ling Xu, MD, Yao Danlin, Tan Jiaxiong, Yu Zhi, Chen Jie, Luo Gengxin, Lijian Yang, Zha Xianfeng, Shaohua Chen, MS, Yangqiu Li

Blood (2017) 130 (Supplement 1): 3591.

https://doi.org/10.1182/blood.V130.Suppl_1.3591.3591

Published: 2017

Journal Articles

High PD-1 and Tim-3 Expression Concurrent with Exhausted CD4+ and CD8+ T Cells in Bone Marrow Compared with Peripheral Blood from Patients with Multiple Myeloma

Jiaxiong Tan, Shaohua Chen, MS, Jingying Huang, Youchun Chen, Lijian Yang, Jun Zhong, Yuhong Lu, Yangqiu Li

Blood (2017) 130 (Supplement 1): 4391.

https://doi.org/10.1182/blood.V130.Suppl_1.4391.4391

Published: 2017

Journal Articles

Whole Exome Sequencing of Plasma Cells Precancerosis MGUS and Malignant AL Amyloidosis Reveals Small Number of Shared Mutated Genes

Zuzana Kufova, Katerina Growkova, Petr Vojta, MSc, Jana Filipova, Michal Simicek, PhD, Tomas Jelinek, Martina Zatopkova, Sebastian Grosicki, MD PhD, Aneta Mikulasova, PhD, Marian Hajduch, MD PhD, Ludek Pour, Doc,MD PhD, Martin Stork, MD, Tereza Sevcikova, PhD, Roman Hajek

Blood (2017) 130 (Supplement 1): 4364.

https://doi.org/10.1182/blood.V130.Suppl_1.4364.4364

Published: 2017

Journal Articles

The Immune Checkpoint Receptors PD-1, PD-L1, TIM-3 and LAG-3 in Lymphoma: Tumor Cell and Tumor Infiltrating Lymphocyte (TIL) Expression, Patient Prognostication, and Identification of Rational Therapeutic Targets

Ravi Dashnamoorthy, PhD, Benjamin Chen, MD PhD, Pallavi Galera, Hong Chang, PhD, Afshin Beheshti, PhD, Srimoyee Ghosh, PhD, Andrew M Evens, DO,MSc

Blood (2017) 130 (Supplement 1): 2750.

https://doi.org/10.1182/blood.V130.Suppl_1.2750.2750

Published: 2017

NARROW

Disulfide exchange in multimerization of von Willebrand factor and gel-forming mucins

Lymphocyte Subpopulations and Expression of Immune Checkpoint Receptors PD-1 and Tim-3 in Patients with Chronic Myeloid Leukemia in a Discontinuation Trial

A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of MBG453 Added to Hypomethylating Agents (HMAs) in Patients (pts) with Intermediate, High, or Very High Risk Myelodysplastic Syndrome (MDS): Stimulus-MDS1

The von Willebrand factor D′D3 assembly and structural principles for factor VIII binding and concatemer biogenesis

Platelet Protein Glycosylation in Immune Thrombocytopenia

Monitoring ESAM Expression Levels Reveals Autonomous Fluctuation of Leukemia Stem Cells By Autocrine/Paracrine Cytokine Signaling

Identification of Molecular Markers of Tumor Cell Sensitivity and Resistance to Natural Killer Cells through Genome-Wide CRISPR Activation and CRISPR Editing Screens in Multiple Myeloma Cell Lines: Implications for Anti-Myeloma Immunotherapy

Nivolumab for Relapsed or Residual Haematological Malignancies after Allogeneic Haematopoietic Stem Cell Transplantation (NIVALLO)

Molecular Resistance Mechanisms in Multiple Myeloma

Endothelial O-Glycoproteins Cooperate with Platelet CLEC-2 Signaling to Maintain Cerebrovascular Integrity during Mouse Development

Oral Nutrition Modulates the Intestinal Barrier Following Cytotoxic Therapy Via the Microbiome

Identification and Molecular Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Niche Factor

Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis

Characteristics of CD4 + and CD8 + Memory T Cell Subsets from Peripheral and Bone Marrow in Patients with Acute Myeloid Leukemia

High PD-1 and Tim-3 Expression Concurrent with Exhausted CD4+ and CD8+ T Cells in Bone Marrow Compared with Peripheral Blood from Patients with Multiple Myeloma

Whole Exome Sequencing of Plasma Cells Precancerosis MGUS and Malignant AL Amyloidosis Reveals Small Number of Shared Mutated Genes

The Immune Checkpoint Receptors PD-1, PD-L1, TIM-3 and LAG-3 in Lymphoma: Tumor Cell and Tumor Infiltrating Lymphocyte (TIL) Expression, Patient Prognostication, and Identification of Rational Therapeutic Targets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only